ANGELI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.625
AS - Asia 5.568
EU - Europa 4.994
SA - Sud America 59
OC - Oceania 20
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 44.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.574
SG - Singapore 2.451
CN - Cina 2.220
IT - Italia 1.176
FI - Finlandia 895
DE - Germania 802
VN - Vietnam 527
SE - Svezia 517
FR - Francia 430
GB - Regno Unito 307
RU - Federazione Russa 302
UA - Ucraina 276
HK - Hong Kong 183
IE - Irlanda 92
IN - India 80
NL - Olanda 51
CA - Canada 43
BR - Brasile 41
TR - Turchia 32
GR - Grecia 22
JP - Giappone 22
AT - Austria 21
TW - Taiwan 17
ES - Italia 15
BE - Belgio 14
DK - Danimarca 14
EG - Egitto 11
AU - Australia 10
CH - Svizzera 10
NZ - Nuova Zelanda 10
EU - Europa 9
LT - Lituania 9
RO - Romania 9
AR - Argentina 8
MX - Messico 7
CL - Cile 6
PK - Pakistan 6
BG - Bulgaria 5
MY - Malesia 5
PL - Polonia 5
CZ - Repubblica Ceca 4
MK - Macedonia 4
PH - Filippine 4
IR - Iran 3
PT - Portogallo 3
SI - Slovenia 3
A1 - Anonimo 2
BD - Bangladesh 2
CY - Cipro 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SC - Seychelles 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 44.294
Salva come PNG Salva come JPEG
Città #
Fairfield 5.254
Woodbridge 3.180
Chandler 2.676
Houston 2.571
Ann Arbor 2.446
Ashburn 2.122
Wilmington 1.860
Seattle 1.825
Cambridge 1.782
Singapore 1.440
Jacksonville 1.174
Boardman 986
Princeton 827
Santa Clara 648
Medford 571
San Diego 533
Dong Ket 524
Roxbury 430
Beijing 421
Nanjing 380
Des Moines 348
Helsinki 331
Padova 321
Guangzhou 190
Hong Kong 180
Shenyang 151
Nanchang 122
Hebei 109
New York 98
Dublin 90
Norwalk 84
Changsha 77
Jiaxing 76
London 72
Tianjin 70
Dearborn 59
Rome 58
Nuremberg 51
Falkenstein 44
Jinan 43
Milan 42
Shanghai 39
Los Angeles 36
Redwood City 33
Hefei 31
Kharkiv 31
Ogden 31
Kunming 30
Yenibosna 28
Munich 27
Bologna 25
Falls Church 24
Villafranca Padovana 24
Kilburn 23
Ningbo 22
Pune 22
Venice 21
Borås 20
Zhengzhou 19
Dallas 18
Washington 17
Toronto 16
Frankfurt am Main 15
Kaohsiung City 15
Chicago 13
Lanzhou 13
Legnaro 13
Nürnberg 13
Taizhou 13
Haikou 12
Hangzhou 12
Hounslow 12
Naples 12
Rockville 12
Trento 12
Amsterdam 11
Catania 11
Florence 11
Ottawa 11
Paris 11
Mestre 10
Vienna 10
Fuzhou 9
Las Vegas 9
Palermo 9
Prescot 9
Salerno 9
Brussels 8
Chiswick 8
Cologno Monzese 8
Duncan 8
Genoa 8
Lappeenranta 8
Tappahannock 8
Tokyo 8
Torino 8
Trieste 8
Chongqing 7
Treviso 7
Turin 7
Totale 35.191
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 198
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 173
Abnormalities in the 24-hour Rhythm of Skin Temperature in Cirrhosis: Sleep-Wake and General Clinical Implications 169
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 166
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 162
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 162
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 158
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 156
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability 155
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 154
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 152
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 151
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis 148
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod 147
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 146
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 144
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 144
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 143
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 141
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis 141
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 139
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 137
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 135
Reply to: "Tools and tactics for improving diagnosis of hepatic encephalopathy" 135
The survival benefit of liver transplantation in hepatocellular carcinoma patients 133
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 132
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 132
Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study 131
A patients' and caregivers' perspective on hepatic encephalopathy. 131
Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis 131
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 130
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 130
The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis 129
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 129
Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine 128
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report 128
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 127
Covert hepatic encephalopathy: agreement and predictive validity of different indices 127
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis 127
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 126
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 126
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites 126
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 125
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 125
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 125
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 125
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 125
An Abnormal Gene Expression of the beta-Adrenergic System Contributes to the Pathogenesis of Cardiomyopathy in Cirrhotic Rats 124
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 124
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study 124
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 123
Meld-na and Survival Benefit In Liver Transplantation 122
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy 122
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure 122
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 122
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 121
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 121
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. 120
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 120
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 119
Positive cardiac inotropic effect of albumin infusion in rats with cirrhosis and ascites: Molecular mechanisms 119
Reply 119
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 118
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection 117
Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis. 117
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 117
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 117
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study 116
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 116
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 116
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology 116
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 116
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) 115
Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites 114
Adjuvant mitotane treatment for adrenocortical carcinoma. 114
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 113
Neurological complications after orthotopic liver transplantation 112
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 112
Urinary Ethyl Glucuronide Improves the Detection of Alcohol Consumption In Liver Transplant Candidates and Recipients 111
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 111
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 110
ERP correlates of cognitive control and food-related processing in normal weight and severely obese candidates for bariatric surgery: Data gathered using a newly designed Simon task 110
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 109
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial 109
Alcohol- and substance-dependent subjects: The correlated factors in qualifying for liver transplantation 109
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 109
Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. 108
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure 108
Why and how to measure renal function in patients with liver disease 108
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 108
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 108
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis 108
Sequential versus "ab initio" combined diuretic treatment of moderate ascites in cirrhotic patients: Preliminary results of a randomized controlled multicenter clinical study 107
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report 107
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 107
Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis 106
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 106
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 106
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 105
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 105
Totale 12.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.950
article - articoli 139.851
book - libri 1.344
conference - conferenze 0
curatela - curatele 0
other - altro 398
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.772
Totale 319.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.473 0 0 0 0 0 0 0 0 908 737 498 330
2020/20215.801 260 479 253 392 189 395 234 530 695 645 697 1.032
2021/20227.025 158 1.034 661 433 355 374 409 622 366 202 595 1.816
2022/20235.602 1.273 500 187 583 950 778 20 316 628 36 274 57
2023/20242.655 149 406 275 227 160 227 176 102 114 95 386 338
2024/20256.358 34 1.088 705 546 1.711 380 626 963 305 0 0 0
Totale 44.746